C Lorenzo, K Williams, KJ Hunt, SM Haffner - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—At baseline, the metabolic syndrome was less prevalent in cohort 1
than in cohort 2: in men, 20.4 vs. 29.3% (P < 0.001); in women, 16.3 vs. 26.3%
(P < 0.001). The prevalence increased in men and women of both ... Cited by 61 - Related articles - BL Direct - All 10 versions
- ►endojournals.org E Ferrannini - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc The other day I saw Mrs. RG, admitted for shortness of breath and fatigue. "A
lady of 59," recited the young intern, "has had type 2 diabetes for 15 yr,
treated with metformin plus glibenclamide, and hypertension, ... Cited by 34 - Related articles - BL Direct - All 4 versions
JA Batsis, RE Nieto-Martinez, F Lopez- … - Clinical Pharmacology and Therapeutics, 2007 - ucilmsa.org The metabolic syndrome (MetS) encompasses a constellation of metabolic
abnormalities that are thought to place patients at higher risk for the
development of diabetes and cardiovascular (CV) disease. The underlying ... Cited by 22 - Related articles - View as HTML - All 4 versions
B Hildrum, A Mykletun, T Hole, K Midthjell, AA … - BMC Public Health, 2007 - biomedcentral.com The 2005 International Diabetes Federation (IDF) definition of the metabolic
syndrome was designed to be useful worldwide, but to date few prevalence studies
have used that definition in European populations. We estimated the age- ... Cited by 23 - Related articles - Cached - All 8 versions
- ►smajournalonline.org ZH Israili, B Lyoussi, R Hernandez- … - American journal of therapeutics, 2007 - journals.lww.com Metabolic syndrome (MetSyndr), a constellation of abnormalities [obesity,
glucose intolerance, insulin resistance (IR), dyslipidemia (low HDL-cholesterol,
high LDL-cholesterol and triglycerides (TG)], and elevated blood pressure ... Cited by 17 - Related articles - BL Direct - All 7 versions
- ►endojournals.org JL Rosenzweig, E Ferrannini, SM Grundy, SM … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Conclusions: Healthcare providers should incorporate into their practice
concrete measures to reduce the risk of developing CVD and T2DM. These include
the regular screening and identification of patients at metabolic risk (at ... Cited by 12 - Related articles - All 5 versions
E Ramírez-Vargas, MR Arnaud-Viñas, H … - Salud Pública de México, 2007 - SciELO Public Health Metabolic syndrome (MS) is a clustering of cardiovascular risk factors, ie
abdominal obesity, low high-density lipoprotein (HDL) cholesterol, elevated
triglycerides, hyperinsulinemia, hyperglycemia and hypertension. 1,2 The ... Cited by 12 - Related articles - Cached - BL Direct - All 7 versions
- ►endojournals.org G Hu, J Lindstrom, P Jousilahti, M Peltonen, L … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Results: In both years the metabolic syndrome was more common among men than
women. In men the prevalence of the metabolic syndrome tended to increase
slightly between 1992 and 2002, from 48.8–52.6% (P = 0.139) based on the ... Cited by 7 - Related articles - All 4 versions
E Bruckert - European Heart Journal Supplements, 2006 - Eur Soc Cardiology Low HDL-cholesterol is a risk factor for adverse cardiovascular outcomes
indepen- dently of levels of LDL-cholesterol. Surveys in individual countries
have revealed a substantial prevalence of low HDL-cholesterol, but the ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►sochob.cl [PDF] C Schindler - Therapeutic Advances in Cardiovascular Disease, 2007 - tak.sagepub.com DOI: 10.1177/1753944707082662 2007; 1; 7 Ther Adv Cardiovasc Dis Christoph
Schindler targeting the pathogenesis? ... Review: The metabolic syndrome as an
endocrine disease: is there an effective pharmacotherapeutic strategy optimally Cited by 9 - Related articles - All 3 versions
